Schrörs, Barbara <br/><br/>
HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model.  [electronic resource] 

 -  Oncotarget  Apr 2017 
 - 28312-28327 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.16048  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alleles<br/>Animals<br/>Antigen Presentation<br/>Antigens, Neoplasm--genetics<br/>Cell Line, Tumor<br/>Computational Biology--methods<br/>Disease Models, Animal<br/>Epitope Mapping<br/>Epitopes, T-Lymphocyte--genetics<br/>Gene Expression Profiling<br/>Genes, MHC Class I<br/>High-Throughput Nucleotide Sequencing<br/>Humans<br/>INDEL Mutation<br/>Melanoma--genetics<br/>Mice<br/>Mutation<br/>Neoplasm Metastasis<br/>Peptides--chemistry<br/>Receptors, Antigen, T-Cell, alpha-beta--genetics<br/>T-Cell Antigen Receptor Specificity--immunology<br/>T-Lymphocytes--immunology<br/>Transcriptome